The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective characterization of circulating tumor cell kinetics in patients treated with radiation therapy per definitive intent oligometastatic paradigm.
 
Shivani Sud
No Relationships to Disclose
 
Michael Poellmann
Employment - Capio BioSciences
 
Jacob Hall
No Relationships to Disclose
 
Xianming Tan
No Relationships to Disclose
 
Jiyoon Bu
No Relationships to Disclose
 
Sin-jung Park
No Relationships to Disclose
 
Seungpyo Hong
Employment - Capio BioSciences
Leadership - Capio BioSciences
Stock and Other Ownership Interests - Capio BioSciences
Consulting or Advisory Role - Capio BioSciences
Patents, Royalties, Other Intellectual Property - Capio BioSciences
 
Andrew Zhuang Wang
Leadership - Abbvie (I); Abbvie (I); Archimmune Therapeutics; Capio BioSciences; Focus-X Therapeutics; Merrimack (I); Merrimack (I); Nanorobotics; Novartis (I)
Stock and Other Ownership Interests - Archimmune Therapeutics; Archimmune Therapeutics; Capio BioSciences
Consulting or Advisory Role - Aptitude Health (I); Aravive (I); AVEO (I); Bayer (I); Capio BioSciences; Dendreon (I); Eisai (I); Gerson Lehrman Group; Janssen (I); Kidney Cancer Association (I); Merck KGaA (I); Mirati Therapeutics (I); MJH Associates (I); Peerview (I); PlatformQ Health (I); QED Therapeutics (I); Regeneron (I); Sanofi/Aventis (I); Seagen (I)
Speakers' Bureau - Exelixis (I); Genentech (I); Sanofi (I)
Research Funding - Accuray; Archimmune Therapeutics; Capio BioSciences (Inst); Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Biomatrix patent licensed to PhoenixSongs
Travel, Accommodations, Expenses - Exelixis (I); Genentech (I); Pfizer (I); Sanofi (I)
 
Dana Casey
No Relationships to Disclose